Risk Mitigation and Reporting Readiness in Clinical Trial Accounting

Learn how life sciences finance and accounting teams can reduce risk, improve audit readiness, and strengthen reporting controls around clinical trial accruals and R&D expenses. In this webinar, Auxilius is joined by Crowe for a discussion on the evolving regulatory landscape, common audit risks, and internal control considerations for clinical trial accounting. The conversation covers why R&D accruals are often a critical audit matter for clinical-stage biopharma companies and what finance teams can do to prepare for greater scrutiny. The discussion also explores how manual spreadsheets, incomplete vendor data, CRO estimates, late invoices, and limited clinical visibility can create reporting risk, audit challenges, and control gaps. Topics include: Why clinical trial accruals are a common critical audit matter How evolving accounting standards are increasing reporting and disclosure requirements Common internal control risks in clinical trial accounting Why spreadsheet-based accrual processes can create audit issues How to improve completeness and accuracy around R&D accruals Best practices for documenting accrual methodology and evidence of review How finance teams can better corroborate vendor estimates with clinical activity How automation can support internal controls, audit readiness, and financial reporting compliance This webinar is useful for biotech finance, accounting, controllership, audit, and clinical operations teams looking to reduce reporting risk, improve clinical trial accrual processes, and build stronger controls around outsourced R&D spend.